Therefore, despite inhibiting PI3K/Akt, Ding-Chuan-Tang's anti-inflammatory and antioxidant effects in COPD are partially mediated through Nrf2 upregulation, further underscoring the therapeutic potential of targeting Nrf2 activation for COPD management. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.